Hypersplenism in schistosomatic portal hypertension
- PMID: 16099328
- DOI: 10.1016/j.arcmed.2005.04.003
Hypersplenism in schistosomatic portal hypertension
Abstract
Background: For many years, the hematologic changes occurring in hepatosplenic Manson's schistosomiasis have been defined as hypersplenism. Initially, the belief was that removal of the spleen would normalize the hematologic values. However, hematimetric normalization was observed in surgeries for the treatment of portal hypertension in which the spleen was preserved. In view of these findings, it is necessary to verify the clinical and laboratory profile of these patients in order to define the real presence of hypersplenism.
Methods: This study was conducted on 51 patients with schistosomatic portal hypertension divided into five groups: group 1, non-operated patients under clinical control; group 2, patients submitted to distal splenorenal shunt; group 3, patients with subtotal splenectomy and central splenorenal shunt; group 4, patients with total splenectomy and central splenorenal shunt; and group 5, patients with total splenectomy and portal-variceal disconnection. Clinical signs of hypersplenism were assessed in all patients. Hematologic values of the pre- and postoperative period were compared. Immunoglobulin counts of the patients were verified in the late postoperative period.
Results: In all operated groups, hematimetric values, leukocyte counts, platelet number and prothrombin time were higher during the postoperative period. With respect to the immunoglobulins, the postoperative values of IgM, IgG and IgA were normal.
Conclusions: Patients with schistosomatic portal hypertension and peripheral cytopenia cannot be classified as having hypersplenism but rather as having pancytopenia due to splenomegaly caused by difficulty on portal blood drainage.
Similar articles
-
Late clinical, biochemical, endoscopic and electroencephalographic evaluation of patients with schistosomal portal hypertension treated with distal splenorenal shunt.Int Surg. 1998 Jan-Mar;83(1):42-7. Int Surg. 1998. PMID: 9706517
-
Splenectomy is contraindicated for thrombocytopenia secondary to portal hypertension.Surg Gynecol Obstet. 1985 Mar;160(3):233-8. Surg Gynecol Obstet. 1985. PMID: 3975794
-
Long-term effects of distal splenorenal shunt with splenopancreatic and gastric disconnection on hypersplenism due to liver cirrhosis.Hepatogastroenterology. 1999 Sep-Oct;46(29):2995-8. Hepatogastroenterology. 1999. PMID: 10576390
-
[Correction of secondary hypersplenism in the surgical treatment of portal hypertension].Vestn Khir Im I I Grek. 1991 Mar;146(3):137-40. Vestn Khir Im I I Grek. 1991. PMID: 1654623 Review. Russian. No abstract available.
-
Portal hypertension in schistosomiasis: pathophysiology and treatment.Mem Inst Oswaldo Cruz. 1992;87 Suppl 4:183-16. doi: 10.1590/s0074-02761992000800028. Mem Inst Oswaldo Cruz. 1992. PMID: 1343892 Review.
Cited by
-
Splenosis after splenectomy and spleen tissue autoimplantation: Late followup study.J Indian Assoc Pediatr Surg. 2012 Jul;17(3):104-6. doi: 10.4103/0971-9261.98120. J Indian Assoc Pediatr Surg. 2012. PMID: 22869974 Free PMC article.
-
TIPS and splenorenal shunt for complications of portal hypertension in chronic hepatosplenic schistosomiasis-A case series and review of the literature.PLoS Negl Trop Dis. 2021 Dec 21;15(12):e0010065. doi: 10.1371/journal.pntd.0010065. eCollection 2021 Dec. PLoS Negl Trop Dis. 2021. PMID: 34932562 Free PMC article. Review.
-
Long-term results of esophagogastric devascularization and splenectomy associated with endoscopic treatment in schistosomal portal hypertension.World J Surg. 2010 Nov;34(11):2682-8. doi: 10.1007/s00268-010-0717-8. World J Surg. 2010. PMID: 20645097
-
THE SPLENIC INDEX AS PREDICTOR OF BLEEDING AND VARICEAL RECURRENCE IN THE LATE FOLLOW-UP OF SCHISTOSOMOTIC PATIENTS AFTER EXCLUSIVE ENDOSCOPIC TREATMENT.Arq Bras Cir Dig. 2022 Jan 31;34(4):e1638. doi: 10.1590/0102-672020210002e1638. eCollection 2022. Arq Bras Cir Dig. 2022. PMID: 35107500 Free PMC article.
-
Subtotal splenectomy preserving the inferior splenic pole for the treatment of Hodgkin's lymphoma.Int J Surg Case Rep. 2017;36:1-3. doi: 10.1016/j.ijscr.2017.04.015. Epub 2017 Apr 25. Int J Surg Case Rep. 2017. PMID: 28486174 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous